Imagining the perspective of someone with ALS I can see why they rightly would be advocating for a quicker process even with the risk. Most people diagnosed wit

Imagining the perspective of someone with ALS I can see why they rightly would be advocating for a quicker process even with the risk. Most people diagnosed with ALS die within 1-5 years depending on how quickly it progresses. They don't have the benefit of waiting on the normal timeline for FDA approvals. The downsides of taking an experimental drug that harms them or just doesn't work is likely worth it for someone in that situation when they look at the potential upsides if it does work. For quickly degenerative diseases maybe we need a different process that takes into account the context of what the drug is used for and what the acceptable risk is by the regulatory bodies. Making the standards and process clear will help provide the framework to reject those with unreasonable demands.